Skip to content

6 New FDA Orphan Drug Designations: Week of 05/18/15

May 22, 2015

 

 

 

 

The chart below identifies 6 new FDA Products Receiving Orphan Designation for the week of 05/18 – 05/22/15 as of 05/22/15 in ascending “Orphan Drug Designation Date” order.

FDA Products Receiving Orphan Drug Designation (Week of 05/18 – 05/22/15)

 # Generic Name/ODD Date Sponsor Company Indication
1 Revusiran/ 05.18 Alnylam Pharmaceuticals Transthyretin Amyloidosis
2 Xenon Gas/ 05.18 Neuroprotexeon (UK) To improve neurological outcome in hospitalized cardiac arrest patients
3 Chloroquine/ 05.20 DualTpharma B.V. (Netherlands) Glioblastoma Multiforme
4 Lutetium (177Lu)-edotreotide/ 05.21 ITG Isotope Technologies Garching GmbH (Germany) Gastro-entero-pancreatic neuroendocrine tumors
5 poly-CD-PEG-camptothecin/ 05.21 Cerulean Pharma Ovarian Cancer
6 Echinomycin/ 05.21 Oncolmmune Inc. Acute Myeloid Leukemia

.

** Generic Name/ODD Date” Column Link = Is the FDA Orphan Drug Product Designation Database Record.

Please Note : “Two small test tubes held in spring clamps” courtesy of  Amitchell125 at English Wikipedia [CC-BY-SA-30] | Wikimedia Commons.

Copyright © 2012-2015, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: